Alpha 2.0
Login Register
» Articles » PMID: 33361145

Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2020 Dec 28
PMID 33361145
Citations 55
Authors
Shivani Agarwal
Justin Mathew
Georgia M Davis
Alethea Shephardson
Ann Levine
Rita Louard
Agustina Urrutia
Citlalli Perez-Guzman
Guillermo E Umpierrez
Limin Peng
Francisco J Pasquel
Affiliations
Soon will be listed here.
Abstract

Objective: Real-time continuous glucose monitoring (rtCGM) in critically ill hospitalized patients holds promise; however, real-world data are needed.

Research Design And Methods: We placed Dexcom G6 CGM on intensive care unit (ICU) patients at Montefiore Medical Center with confirmed coronavirus disease 2019 (COVID-19) infection and glycemic variability. We analyzed inpatient CGM accuracy using point-of-care (POC) glucose-CGM matched pairs and included patients for analysis regardless of clinical status.

Results: We included 11 patients with CGM: 8 on continuous insulin infusion (CII), 8 on vasopressors, 8 intubated, 4 on high-dose glucocorticoids, 6 on renal replacement therapy, and 2 with anasarca. Accuracy was 12.58% for mean and 6.3% for median absolute relative difference. CGM reduced POC testing by ∼60% for patients on CII.

Conclusions: In this real-world preliminary analysis of rtCGM during critical illness, we demonstrate early feasibility, considerable accuracy, and meaningful reduction in the frequency of POC glucose testing.

Citing Articles

Effectiveness of Continuous Glucose Monitoring on Short-Term, In-Hospital Mortality Among Frail and Critically Ill Patients With COVID-19: Randomized Controlled Trial.

Shang J, Yuan Z, Zhang Z, Zhou Q, Zou Y, Wang W J Med Internet Res. 2025; 27:e67012.

PMID: 39918851 PMC: 11845876. DOI: 10.2196/67012.

Continuous Glucose Monitoring in Hospitalized Adults With Diabetic Ketoacidosis: A Prospective Open-Label Pilot Study.

Bogun M, Wang C, Kurlansky P, Bedeir N, Umpierrez G J Diabetes Sci Technol. 2025; :19322968251316887.

PMID: 39907056 PMC: 11800229. DOI: 10.1177/19322968251316887.

7. Diabetes Technology: Standards of Care in Diabetes-2025.

Diabetes Care. 2024; 48(Supplement_1):S146-S166.

PMID: 39651978 PMC: 11635043. DOI: 10.2337/dc25-S007.

The Performance of Continuous Glucose Monitoring During the Intraoperative Period: A Scoping Review.

Lim H, Kim M, Kim N, Huh J, Jeong J, Hwang W J Clin Med. 2024; 13(20).

PMID: 39458119 PMC: 11508367. DOI: 10.3390/jcm13206169.

Using technology to support diabetes care in hospital: Guidelines from the Joint British Diabetes Societies for Inpatient Care (JBDS-IP) group and Diabetes Technology Network (DTN) UK.

Avari P, Choudhary P, Lumb A, Misra S, Rayman G, Flanagan D Diabet Med. 2024; 42(3):e15452.

PMID: 39432570 PMC: 11823341. DOI: 10.1111/dme.15452.

References
1.
Ushigome E, Yamazaki M, Hamaguchi M, Ito T, Matsubara S, Tsuchido Y . Usefulness and Safety of Remote Continuous Glucose Monitoring for a Severe COVID-19 Patient with Diabetes. Diabetes Technol Ther. 2020; 23(1):78-80. DOI: 10.1089/dia.2020.0237. View
2.
Davis G, Galindo R, Migdal A, Umpierrez G . Diabetes Technology in the Inpatient Setting for Management of Hyperglycemia. Endocrinol Metab Clin North Am. 2020; 49(1):79-93. PMC: 7453786. DOI: 10.1016/j.ecl.2019.11.002. View
3.
Reutrakul S, Genco M, Salinas H, Sargis R, Paul C, Eisenberg Y . Feasibility of Inpatient Continuous Glucose Monitoring During the COVID-19 Pandemic: Early Experience. Diabetes Care. 2020; 43(10):e137-e138. PMC: 7876554. DOI: 10.2337/dc20-1503. View
4.
Shah V, Laffel L, Wadwa R, Garg S . Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator. Diabetes Technol Ther. 2018; 20(6):428-433. PMC: 6422005. DOI: 10.1089/dia.2018.0143. View
5.
Ancona P, Eastwood G, Lucchetta L, Ekinci E, Bellomo R, Martensson J . The performance of flash glucose monitoring in critically ill patients with diabetes. Crit Care Resusc. 2017; 19(2):167-174. View